Unexplained weight loss (UWL), defined as a decrease in body weight of 5% or more within a six-month period, poses a diagnostic challenge for clinicians. Despite its potential implications for serious underlying conditions, a standardized approach to evaluating UWL remains elusive, often leading to diagnostic uncertainty and patient anxiety.
UWL can be indicative of various underlying conditions, including malignancies, gastrointestinal disorders, endocrine diseases, psychiatric illnesses, and infectious diseases. However, in up to 25% of cases, no clear etiology is identified, even after extensive evaluation.
A comprehensive diagnostic approach to UWL should include a thorough history and physical examination, focusing on symptoms that might indicate specific diseases. If the initial evaluation is unrevealing, laboratory testing, imaging studies, and specialist consultations may be warranted. The diagnostic yield of these investigations varies, and the choice of tests should be guided by the patient's clinical presentation.
Imaging studies play an important role in evaluating UWL, particularly when malignancy is suspected. However, the routine use of imaging in all patients with UWL is not recommended due to the risk of false-positive results and unnecessary radiation exposure. The decision to use imaging should be based on individual patient factors and the likelihood of a positive result.
Management of UWL depends on the underlying cause. If no cause is identified, regular follow-up is essential, as new symptoms may emerge over time. Re-evaluation should be considered if the patient continues to lose weight or develops new symptoms.
UWL poses a significant diagnostic challenge due to its broad differential diagnosis. A systematic and patient-centered approach can help clinicians navigate this complexity, ensuring timely diagnosis and appropriate management. Continued research is needed to refine the evaluation process and improve outcomes for patients with UWL.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation